Evaluation of the Use of Synthetic Glue for Mesh Fixation in Laparoscopic Sacrocolpopexy (LSCGlue)

The aim of the study is to evaluate the effect of cyanoacrylate adhesive in laparoscopic sacrocolpopexy, which is the gold standard treatment for apical prolapse. The procedure is predominantly performed using minimally invasive techniques, such as laparoscopic or robotic methods. However, the operative time for this procedure often exceeds 180 minutes due to its technical complexity. Although the experience level of the surgical team can lead to a decrease in operative time, there is a concerning increase in the risk of postoperative complications as the duration of surgery extends. One strategy to mitigate overall operative time is to reduce the fixation time of the implant to the vaginal wall.

Standard fixation involves using several sutures, but alternative fixation methods, including barbed sutures and cyanoacrylate adhesives, may demonstrate a reduction in fixation time. While there are only a few studies available on the use of cyanoacrylate adhesives for implant fixation, they generally indicate that this method is safe and can achieve an objective success rate of over 96% in resolving apical descent. However, the reported operative time using glue varies significantly across studies, ranging from 69 to 173 minutes.

The aim of the current study is to assess the impact of a synthetic cyanoacrylate-based tissue adhesive on various factors, including implant fixation time, overall length of surgery, short- and long-term postoperative complications, risk of prolapse recurrence, and the cost-effectiveness of this method in comparison to traditional laparoscopic sutures. This will be conducted as a randomized prospective monocentric study that includes patients aged 18 to 75 years diagnosed with pelvic organ descent grade 2 or higher. Notably, individuals requiring uterine preservation, having undergone previous hysterectomy, or with precancerous or malignant uterine diseases will be excluded.

The surgical approach will involve fixing the implant to the vaginal wall with cyanoacrylate adhesive in the target group, along with non-absorbable sutures. In contrast, the control group will follow traditional fixation methods using absorbable sutures in addition to non-absorbable ones. The study will evaluate outcomes using various questionnaires, including the POPQ for anatomical effect and PFDI-20 for subjective discomfort, while also assessing postoperative pain through the VAS scale.

Expected results include a targeted reduction in implant fixation time by at least 20 minutes and a comprehensive evaluation of the method's cost-effectiveness based on reports from Brno University Hospital. This study is significant as it represents the first prospective randomized trial to investigate the effects of cyanoacrylate adhesive on operative time and cost-effectiveness compared to conventional suturing in laparoscopic sacrocolpopexy

Study Overview

• Status: Recruiting
• Conditions: Apical Prolapse; Sacrocolpopexy; Glue Fixation
• Intervention / Treatment: Procedure: cyanoacrylate tissue adhesive beside sutures; Procedure: Suture

• Study Type: Interventional
• Enrollment (Estimated): 40
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Samuel Tvarožek, MD; Phone Number: +420532238207; Email: tvarozek.samuel@fnbrno.cz
• Study Contact Backup: Name: Martina Szypulová, MD; Phone Number: +420532233975; Email: szypulova.martina@fnbrno.cz

Study Locations

• Czechia
  • Czech Republic
    • Brno, Czech Republic, Czechia, 62500
      • Recruiting
      • Brno University Hospital
      • Contact: Samuel Tvarožek, MD; Phone Number: +420532238207; Email: tvarozek.samuel@fnbrno.cz
      • Principal Investigator: Samuel Tvarožek, MD
      • Sub-Investigator: Martina Szypulová, MD
      • Sub-Investigator: Anežka Šteflová, MD
      • Sub-Investigator: Martina Dostalová, MD
      • Sub-Investigator: Martin Huser, MD, PhD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Sufficient knowledge of the Czech language
• Pelvic organs prolapse of second stage or higher according to POPQ classification (POPQ ≥ 2)
• Patients indicated for laparoscopic sacropexy - sacrocervicopexy with concomitant supracervical hysterectomy

Exclusion Criteria:

• Patients requesting uterine preservation
• Patients with previous hysterectomy
• Patients with premalignancy or malignancy of the female reproductive organs
• Concomitant urethropexy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Glue mesh fixation; The mesh will be fixed to the vaginal walls using cyanoacrylate tissue adhesive.	Procedure: cyanoacrylate tissue adhesive beside sutures; A supracervical hysterectomy will be performed in the standard manner. Uterine amputation above the cervix will be performed with a monopolar needle or scissors. Concomitant adnexal surgery will be performed according to the presence of adnexa and the patient's request or medical indication. In this study group, the implant is secured to the vaginal wall with cyanoacrylate tissue adhesive. Fixation of the implant to the cervix and promontory will be identical to the control group.
Active Comparator: Standard Care (Control): The mesh will be fixed to the vaginal walls using a standard absorbable suture.	Procedure: Suture; A supracervical hysterectomy will be performed in the standard manner. Uterine amputation above the cervix will be performed with a monopolar needle or scissors. Concomitant adnexal surgery will be performed according to the presence of adnexa and the patient's request or medical indication. In this control group, the mesh will be fixed to the cervix with four non-absorbable sutures. In addition, the implant will be fixed to the anterior vaginal wall with four absorbable sutures and to the posterior vaginal wall with four absorbable sutures. The implant will be secured to the promontory with one non-absorbable suture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The duration of fixation of the implant to the walls of the vagina with the adhesive in comparison to the standard suture.	To determine whether or not the duration of fixation of the implant to the anterior and posterior vaginal walls using adhesive is statistically significantly shorter in minutes compared to standard fixation using sutures. The statistical evaluation will be based on time measured with a stopwatch (minutes). The time is measured from the start of fixation of the implant to the vaginal walls until it is completely anchored to the vaginal walls. This objective does not evaluate the time required for complete fixation of the implant including fixation to the promotorium, but only the time required to fix the implant to the vagina.	Enrollment to surgery: 4-8 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Total mesh fixation time	The total time (in minutes) required to manipulate the implant - from its insertion into the abdominal cavity to its fixation to the promontory (including fixation to the cervix and vaginal walls). The total time required for implant fixation between the two groups will be analyzed.	Enrollment to surgery: 4-8 weeks
Total time of the operation	The total operative time (in minutes) is defined as the interval from the initial placement of all laparoscopic trocars to their subsequent removal. A statistical evaluation will be conducted to compare the total time required to complete the surgical procedure between the two groups.	Enrollment to surgery: 4-8 weeks
Peri- and post-operative complications	All perioperative and all postoperative complications will be monitored. The severity of postoperative complications will be assessed according to the Clavien-Dindo classification.	From surgery to 12 months
Perioperative pain intensity and analgetic utilization	All patients will receive analgesics during the postoperative period in accordance with the prevailing therapeutic protocol at the Gynecology and Obstetrics Clinic of the University Hospital Brno. The intensity of pain experienced by patients in the postoperative period will be documented using the Visual Analogue Scale (VAS 0-10) at 6, 24, and 48 hours following surgery. Furthermore, the necessity for opioid analgesics to manage pain will be documented. Subsequent analyses will compare the two groups with respect to the necessity of analgesic and opioid analgesic utilization in the early postoperative period.	intervals: 6, 24 and 48 hours after surgery
Recurrence rate of pelvic organ prolapse	In the late postoperative period (6 and 12 months), the recurrence of pelvic organ prolapse will be assessed in each compartment using a standardized Pelvic Organ Prolapse Quantification System (POP-Q). A finding of Ba ≥ -1, Bp ≥ -1, or C > TVL/2 is considered a recurrence. A statistical comparison will be conducted to evaluate the incidence of recurrence between the two groups.	6 to 12 months
The degree of bother and distress caused by pelvic floor symptoms.	Pelvic Floor Disability Index (PFDI-20) - This is a short form that provides a comprehensive assessment of the impact of pelvic floor disorders on women's quality of life. The PFDI-20 consists of 3 scales, including the Urinary Distress Inventory-6 (UDI-6), the Pelvic Organ Prolapse Distress Inventory-6 (POPDI-6) and the Colorectal-Anal Distress Inventory-8 (CRADI-8). The PFDI-20 serves the role of both a symptom inventory and a measure of the degree of bother and distress caused by the broad array of pelvic floor symptoms. Lower scores indicate less distress caused by the presence of pelvic floor dysfunction symptoms. A comparative analysis of the groups will be performed in relation to the change in subjective perception of difficulties, as assessed by the PFDI-20, after surgery at predetermined intervals.	change from baseline to 8-12 weeks, 6 and 12 months
The impact of a floor dysfunction on the quality of life	The Pelvic Floor Impact Questionnaire-7 (PFIQ-7) is a health-related quality-of-life questionnaire to assess life impact in women with pelvic floor disorders. The questionnaire incorporates scales from the Urinary Impact Questionnaire (UIQ-7), the Pelvic Organ Prolapse Impact Questionnaire (POPIQ-7) and the Colorectal-Anal Impact Questionnaire-7 (CRAIQ-7). The emphasis of the questionnaire is directed towards the impact of pelvic discomfort on the day-to-day activities of the individual. The PFIQ-7 is a valuable tool for measuring changes in symptom severity over time, both before and after treatment, and as such is a useful addition to the existing array of health-related quality-of-life questionnaires. A comparative analysis of the groups will be performed in relation to the change in health-related quality of life, as assessed by the PFIQ-7, after surgery at predetermined intervals.	change from baseline to 8-12 weeks, 6 and 12 months
Quality of life of women with urinary incontinence	International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) - A questionnaire for evaluating the frequency, severity and impact on quality of life (QoL) of urinary incontinence in men and women. where higher scores indicate greater symptom severity. This tool determines the change from baseline - improvement or deterioration of urinary incontinence and will be used as a screening tool for de-novo urinary incontinence after surgery. Additionally, it includes a self-diagnostic item to help identify the type of incontinence. A comparative analysis of the groups will be performed in relation to urinary incontinence and de-novo urinary incontinence after surgery at predetermined intervals.	change from baseline to 8-12 weeks, 6 and 12 months
Sexual function evaluation	The PISQ-IR (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised) is a validated evaluation tool for the assessment of female sexual function in women with female pelvic floor disorders. The PISQ-IR is composed of multiple domains that address different aspects of sexual function. The single summary score will be used to evaluate change from baseline in both groups. Moreover, the individual domains of the questionnaire will be evaluated separately. A comparative analysis of the groups will be performed in relation to the change in sexual functions after surgery.	change from baseline to 8-12 weeks, 6 and 12 months
The patient's subjective impression of improvement since surgery	The Patient Global Imression of Improvement (PGI-I) is a global index that may be used to rate the response of a condition to a therapy. The PGI-I indicates overall satisfaction with post-operative condition based on this scale: 1. Very much better; 2. Much better; 3. A little better; 4. No change; 5. A little worse; 6. Much worse; 7. Very much worse. The PGI-I will be utilized to evaluate patient satisfaction with the postoperative status in comparison to the preoperative status. The patient will complete the PGI-I at predefined postoperative intervals 8-12 weeks, 6 and 12 months. Subsequently, a comparative analysis of the two groups will be performed on patient satisfaction with the postoperative condition.	change from baseline to 8-12 weeks, 6 and 12 months
Position of the implant	The position of the implant will be measured using transperineal and transvaginal ultrasound. The position will be measured as a distance (in millimeters) of the lowermost visible mesh echogenicity from the bladder neck on the anterior vaginal wall and from the perineum on the posterior vaginal wall. A comparative analysis of the implant position in the two study groups will be conducted to ascertain whether the method of fixation exerts an influence on implant placement.	change from baseline to 8-12 weeks, 6 and 12 months
Mesh related complications	Any postoperative mesh complications associated with the implant will be recorded using a Prosthesis/Graft Complication Classification Code for both groups. The calculation will be made using the official IUGA/ICS classification tool available from: https://www.ics.org/complication	From surgery to 12 months
Total cost of care using adhesive fixation versus standard laparoscopic intracorporeal suturing	This part of the study aims to evaluate the total cost of care using adhesive fixation versus standard laparoscopic intracorporeal suturing. The cost of adhesive materials and applicators is significant compared to suture-only methods; however, if adhesive use reduces operative time considerably, financial savings may be achieved. The Controlling Department of University Hospital Brno will provide reports to assess total hospitalization costs, expressed in Czech crowns, which include material, operating room, and postoperative care expenses. These reports will be available three months post-discharge. The study seeks to compare hospitalization costs for adhesive fixation and conventional procedures.	3 months after surgery

Collaborators and Investigators

• Sponsor: Brno University Hospital
• Investigators: Principal Investigator: Samuel Tvarozek, MD, Department of Obstetrics and Gynecology, University Hospital Brno, Brno, Czech Republic

Study record dates

Study Major Dates

• Study Start (Actual): March 11, 2025
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2027

Study Registration Dates

• First Submitted: March 3, 2025
• First Submitted That Met QC Criteria: March 10, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: March 18, 2025
• Last Verified: March 1, 2025

More Information

Terms related to this study

• Keywords: implant fixation; laparoscopic sacrocolpopexy; cyanoacrylate glue; mesh fixation; Tissue Adhesive; Surgical Glue
• Additional Relevant MeSH Terms: Pathological Conditions, Anatomical; Prolapse
• Other Study ID Numbers: 2025069LSCGlue; SUp 6/25 (Other Grant/Funding Number: The University Hospital Brno Start-up grant)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: all IPD that underlie results in a publication
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; SAP; ICF; CSR

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No